To assess immune system remodeling and T cell subset dynamic changes upon recovery from COVID-19 of different severity, we studied CD4+ T cells, regulatory T cells (Tregs) and CD8+ T cells in convalescent patients at time-points I and II, as well as in healthy donors, using 28 parameter full spectrum flow cytometry. This evidence concerns the gene CD8A and COVID-19.